Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Part 1: When to test
PARP inhibition in the treatment of prostate cancer
Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 5: BRCA 1/2 mutations and prostate cancer
PARP inhibition in the treatment of prostate cancer
Part 5: BRCA 1/2 mutations and prostate cancer ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
OncoAlert and ecancer weekly round up for July 12- July 18, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for July 12- July 18, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
19 Jul 2021
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer ( Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy )
19 Jul 2021
Lineage plasticity in lung cancer- biological and therapeutic implications
Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA
Lineage plasticity in lung cancer- biological and therapeutic implications ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA )
16 Jul 2021
ASCO 2021: Precision and molecular reporting for prostate cancer
Prof Eleni Efstathiou - Houston Methodist Cancer Center, Houston, USA
ASCO 2021: Precision and molecular reporting for prostate cancer ( Prof Eleni Efstathiou - Houston Methodist Cancer Center, Houston, USA )
29 Jun 2021
Advances in lung cancer and current situation in Romania
Dr Serban Negru - University of Medicine and Pharmacy Victor Babes Timisoara, On...
Advances in lung cancer and current situation in Romania ( Dr Serban Negru - University of Medicine and Pharmacy Victor Babes Timisoara, OncoHelp Cancer Center )
21 Jun 2021
ALCSI: Raising lung cancer screening awareness in the US
Priyanka Senthil - American Lung Cancer Screening Initiative
ALCSI: Raising lung cancer screening awareness in the US ( Priyanka Senthil - American Lung Cancer Screening Initiative )
17 Jun 2021
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or ...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
14 Jun 2021
Real world evidence on the use of antibody drug conjugates in peripheral T-cell ...
Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Leba...
Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma ( Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon )
14 Jun 2021
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC
Dr Christina Baik - University of Washington School of Medicine, Seattle, USA
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC ( Dr Christina Baik - University of Washington School of Medicine, Seattle, USA )
11 Jun 2021
ELEVATE-TN: Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in t...
Dr Jeff Sharman - Willamette Valley Cancer Institute, Eugene, USA
ELEVATE-TN: Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve CLL - Four-year follow up ( Dr Jeff Sharman - Willamette Valley Cancer Institute, Eugene, USA )
11 Jun 2021